129 related articles for article (PubMed ID: 34154029)
21. Subclinical Hypothyroidism in PCOS: Impact on Presentation, Insulin Resistance, and Cardiovascular Risk.
Yu Q; Wang JB
Biomed Res Int; 2016; 2016():2067087. PubMed ID: 27478827
[TBL] [Abstract][Full Text] [Related]
22. Negative impact of polycystic ovary syndrome on bone health: a systematic review and meta-analysis.
Piovezan JM; Premaor MO; Comim FV
Hum Reprod Update; 2019 Sep; 25(5):633-645. PubMed ID: 31374576
[TBL] [Abstract][Full Text] [Related]
23. [Subclinical hypothyroidism and endocrine metabolic characteristics in women with polycystic ovary syndrome].
Yue F; Zhang D; Gong F; Zhang L; Sun Z; Lei M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 42(8):940-946. PubMed ID: 28872086
[TBL] [Abstract][Full Text] [Related]
24. The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: an euglycaemic-hyperinsulinaemic clamp study.
Tagliaferri V; Romualdi D; Guido M; Mancini A; De Cicco S; Di Florio C; Immediata V; Di Segni C; Lanzone A
Eur J Endocrinol; 2016 Nov; 175(5):433-41. PubMed ID: 27511825
[TBL] [Abstract][Full Text] [Related]
25. Influence of Subclinical Hypothyroidism on Women With Polycystic Ovary Syndrome: A Literature Review.
Peddemul A; Tejovath S; Hassan D; K Patel K; Sikandar R; Kahlon SS; Nair S; Mostafa JA
Cureus; 2022 Aug; 14(8):e28468. PubMed ID: 36176844
[TBL] [Abstract][Full Text] [Related]
26. Effect of Lifestyle Intervention on Cardiometabolic Risk Factors in Overweight and Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
Khatlani K; Njike V; Costales VC
Metab Syndr Relat Disord; 2019 Dec; 17(10):473-485. PubMed ID: 31513475
[TBL] [Abstract][Full Text] [Related]
27. The effect of glycaemic control in type 2 diabetic patients with subclinical hypothyroidism.
Fu X; Xia H; Mao H; Zhao S; Wang Z
J Endocrinol Invest; 2016 Dec; 39(12):1453-1458. PubMed ID: 27476072
[TBL] [Abstract][Full Text] [Related]
28. Impact of Subclinical Hypothyroidism on Reproductive and Metabolic Parameters in Polycystic Ovary Syndrome - A Cross-sectional Study from Bangladesh.
Kamrul-Hasan A; Aalpona FTZ; Selim S
Eur Endocrinol; 2020 Oct; 16(2):156-160. PubMed ID: 33117449
[TBL] [Abstract][Full Text] [Related]
29. Effects of cinnamon on controlling metabolic parameters of polycystic ovary syndrome: A systematic review and meta-analysis.
Heydarpour F; Hemati N; Hadi A; Moradi S; Mohammadi E; Farzaei MH
J Ethnopharmacol; 2020 May; 254():112741. PubMed ID: 32151755
[TBL] [Abstract][Full Text] [Related]
30. Subclinical hypothyroidism is associated with metabolic syndrome and clomiphene citrate resistance in women with polycystic ovary syndrome.
Lu YH; Xia ZL; Ma YY; Chen HJ; Yan LP; Xu HF
Gynecol Endocrinol; 2016 Oct; 32(10):852-855. PubMed ID: 27172176
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of coenzyme Q10 supplementation on glucose metabolism, lipid profiles, and biomarkers of inflammation in women with polycystic ovary syndrome: A protocol for a systematic review and meta-analysis.
Liu M; Zhu H; Hu X; Zhu Y; Chen H
Medicine (Baltimore); 2020 Nov; 99(46):e23130. PubMed ID: 33181684
[TBL] [Abstract][Full Text] [Related]
32. High Serum Tumor Necrosis Factor-Alpha Levels in Women with Polycystic Ovary Syndrome: A Meta-Analysis.
Gao L; Gu Y; Yin X
PLoS One; 2016; 11(10):e0164021. PubMed ID: 27764100
[TBL] [Abstract][Full Text] [Related]
33. Associations between TNF-α and interleukin gene polymorphisms with polycystic ovary syndrome risk: a systematic review and meta-analysis.
Wu H; Yu K; Yang Z
J Assist Reprod Genet; 2015 Apr; 32(4):625-34. PubMed ID: 25690158
[TBL] [Abstract][Full Text] [Related]
34. Association of subclinical hypothyroidism and phenotype, insulin resistance, and lipid parameters in young women with polycystic ovary syndrome.
Ganie MA; Laway BA; Wani TA; Zargar MA; Nisar S; Ahamed F; Khurana ML; Ahmed S
Fertil Steril; 2011 May; 95(6):2039-43. PubMed ID: 21333983
[TBL] [Abstract][Full Text] [Related]
35. Subclinical hypothyroidism in patients with polycystic ovary syndrome: distribution and its association with lipid profiles.
Huang R; Zheng J; Li S; Tao T; Liu W
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():52-6. PubMed ID: 24768234
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of vitamin D supplementation on lipid profile in polycystic ovary syndrome women: a meta-analysis of randomized controlled trials.
Luo J; Li T; Yuan J
Ann Palliat Med; 2021 Jan; 10(1):114-129. PubMed ID: 33545752
[TBL] [Abstract][Full Text] [Related]
37. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.
Cooney LG; Lee I; Sammel MD; Dokras A
Hum Reprod; 2017 May; 32(5):1075-1091. PubMed ID: 28333286
[TBL] [Abstract][Full Text] [Related]
38. The Effects of Supplementation with Chromium on Insulin Resistance Indices in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Heshmati J; Omani-Samani R; Vesali S; Maroufizadeh S; Rezaeinejad M; Razavi M; Sepidarkish M
Horm Metab Res; 2018 Mar; 50(3):193-200. PubMed ID: 29523006
[TBL] [Abstract][Full Text] [Related]
39. Polycystic Ovary Syndrome, Subclinical Hypothyroidism, the Cut-Off Value of Thyroid Stimulating Hormone; Is There a Link? Findings of a Population-Based Study.
Rojhani E; Rahmati M; Firouzi F; Saei Ghare Naz M; Azizi F; Ramezani Tehrani F
Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673125
[TBL] [Abstract][Full Text] [Related]
40. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women.
Shi Y; Gao X; Sun X; Zhang P; Chen Z
Fertil Steril; 2008 Oct; 90(4):1139-43. PubMed ID: 17889857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
